Nutex Health Inc. (NUTX)
NASDAQ: NUTX · Real-Time Price · USD
30.33
+1.55 (5.39%)
Nov 20, 2024, 4:00 PM EST - Market closed
Nutex Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Nutex Health stock have an average target of 55, with a low estimate of 50 and a high estimate of 60. The average target predicts an increase of 81.34% from the current stock price of 30.33.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Nutex Health stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $45 → $50 | Strong Buy | Maintains | $45 → $50 | +64.85% | Nov 12, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $45 → $60 | Strong Buy | Maintains | $45 → $60 | +97.82% | Nov 12, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +48.37% | Sep 18, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $30 → $45 | Strong Buy | Maintains | $30 → $45 | +48.37% | Aug 21, 2024 |
| Benchmark | Benchmark | Strong Buy Maintains $15 → $10 | Strong Buy | Maintains | $15 → $10 | -67.03% | Jan 25, 2024 |
Financial Forecast
Revenue This Year
302.75M
from 247.65M
Increased by 22.25%
Revenue Next Year
355.34M
from 302.75M
Increased by 17.37%
EPS This Year
-0.52
from -10.50
EPS Next Year
1.53
from -0.52
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 316.3M | 370.2M | 412.7M |
| Avg | 302.8M | 355.3M | 400.9M |
| Low | 286.6M | 337.3M | 385.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 27.7% | 22.3% | 16.1% |
| Avg | 22.3% | 17.4% | 12.8% |
| Low | 15.7% | 11.4% | 8.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.41 | 2.91 | 4.77 |
| Avg | -0.52 | 1.53 | 4.63 |
| Low | -1.37 | 0.23 | 4.45 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | 211.6% |
| Avg | - | - | 202.7% |
| Low | - | - | 190.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.